MBRX - Moleculin Biotech, Inc.
2.08
-0.160 -7.692%
Share volume: 178,604
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$2.24
-0.16
-0.07%
Summary score
6%
Profitability
0%
Dept financing
9%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.57%
Return on assets
-14.38%
Return on sales
0%
Return on invested capital
-75.76%
Total debt ratio
24.94%
Debt ratio change over timeo
0%
Current Ratio
3.87%
Quick Ratio
0%
Cash Position Ratio
3.48%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-29.71%
Return on assets
-17.45%
Return on sales
0%
Return on invested capital
-196.74%
Total debt ratio
41.51%
Debt ratio change over timeo
0%
Current Ratio
3.75%
Quick Ratio
0%
Cash Position Ratio
3.12%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-64.7%
Return on assets
-16.04%
Return on sales
0%
Return on invested capital
-128.13%
Total debt ratio
50.19%
Debt ratio change over time
0%
Current Ratio
5.28%
Quick Ratio
0%
Cash Position Ratio
4.48%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MBRX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -18.57% | 17.45% | 4.69% | -3.05% |
| Return on assets | -14.38% | 3.37% | 3.35% | 3.6% |
| Return on sales | 0% | 23.96% | 25.96% | 32.14% |
| Return on invested capital | -75.76% | 5.2% | 4.37% | 5.09% |
| Profitability | 0% | 92% | 71% | 74% |
| Total debt ratio | 24.94% | 77% | 57.66% | 101.18% |
| Debt ratio change over time | 0% | 0% | 10.55% | 69.81% |
| Dept financing | 6% | 19% | 18% | 50% |
| Current Ratio | 3.75% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 3.12% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 30% | 39% | 40% |
| Short-term ratios | MBRX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -29.71% | 44.06% | 6.24% | -25.62% |
| Return on assets | -17.45% | 3.88% | 3.22% | 3.26% |
| Return on sales | 0% | 27.04% | 24.93% | 31.22% |
| Return on invested capital | -196.74% | 9.69% | 4.96% | 8.14% |
| Profitability | 0% | 97% | 57% | 67% |
| Total debt ratio | 41.51% | 91.8% | 61.39% | 105.33% |
| Debt ratio change over time | 0% | 0% | 12.93% | 15.97% |
| Dept financing | 10% | 22% | 35% | 50% |
| Current Ratio | 3.75% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 3.12% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 20% | 26% | 51% |